4
Changes in Ownership
Dolby Laboratories, Inc. Filed Acc 0000950170-24-138158
EVP, Gen. Counsel & Secretary sold 12,338 shares at an average $78.08 ($963,303)
- EVP, Gen. Counsel & Secretary gave up 8,867 shares (to pay taxes)
- EVP, Gen. Counsel & Secretary acquired 20,085 shares (grant or award)
- EVP, Gen. Counsel & Secretary acquired 5,192 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
SHERMAN MARK ANDREW · EVP, Gen. Counsel & Secretary
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-12-16 | Grant or award : show line 1 in the form 10b5-1 | +20,085 | 78,410 | D | ||
| 2024-12-16 | Exercise or conversion : show line 2 in the form 10b5-1 | +5,192 | 83,602 | D | ||
| 2024-12-16 | Shares withheld for taxes : show line 3 in the form 10b5-1 | −8,867 | $79.18 | $702,089 | 74,735 | D |
| 2024-12-17 | Sale : show line 4 in the form 10b5-1 | −4,625 | $77.83 | $359,986 | 70,110 | D |
| 2024-12-17 | Sale : show line 5 in the form 10b5-1 | −7,713 | $78.22 | $603,317 | 62,397 | D |
| Open-market sales · 12,338 sh · avg $78.08 · $963,303 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-12-16 | Grant or award : show line 6 in the form 10b5-1 Performance-Based Restricted Stock Unit | +10,042 | 10,042 | D |
| 2024-12-16 | Grant or award : show line 7 in the form 10b5-1 Employee Stock Option (Right to Buy) | +35,307 | 35,307 | D |
| 2024-12-16 | Exercise or conversion : show line 8 in the form 10b5-1 Performance-Based Restricted Stock Unit | −5,192 | 0 | D |
Loading xslF345X05/ownership.xml…